Capillary pCO2 helps determine IPAH diagnosis

Capillary pCO2 (PcCO2) can be used to distinguish idiopathic pulmonary arterial hypertension (IPAH) from pulmonary hypertension due to heart failure with preserved ejection fraction (PH-HFpEF), research indicates.

The researchers, from Hannover Medical School in Germany, say that the finding could help reduce the number of misclassifications of the two conditions.

The team enrolled 99 patients with IPAH and 86 with PH-HFpEF. They found that at the time of diagnosis, patients in the PH-HFpEF group tended to have PcCO2 values in the normal range, at an average of 40 mmHg. However, in the IPAH group the average PcCO2 was significantly lower, at an average of 33 mmHg.

Receiver operating characteristics analysis suggested that PcCO2 may be helpful in distinguishing between the two conditions: a value of 36 mmHg was most accurate for this purpose, with an area under the curve value of 0.87.

The team found that measurement of PcCO2 provided relevant diagnostic information for 49% of their patients; a value below 34 mmHg excluded PH-HFpEF with a likelihood of over 90%, while a PcCO2 value over 41 mmHg was associated with a less than 10% probability of IPAH.

Writing in Respiratory Research, Karen Olsson and colleagues explain that, while classifying most patients with PH into one of the five subgroups for the condition is straightforward, it has become increasingly challenging to discriminate between those with IPAH and those with PH-HFpEF.

“This distinction, however, is of fundamental practical importance as the treatment of IPAH differs substantially from the treatment of patients with PH-HFpEF”, they note.

The authors say that invasive measurements used to diagnose IPAH and PH-HFpEF based on whether patients have pre- or post-capillary PH can give misleading results leading to misclassification.

“In the past, this problem was less evident as IPAH was originally considered predominantly a disease of younger women, and these patients are not at risk for developing HFpEF”, they write.

“More recently, however, IPAH is increasingly diagnosed in older patients, many of whom present with risk factors for developing left heart disease.”

Olsson and colleagues say that additional non-invasive variables, such as PcCO2 could be useful for distinguishing between the two conditions.

“Further studies are needed to determine the value of PcCO2 in the diagnostic work-up of patients with PH”, they conclude.

Licensed from medwireNews with permission from Springer Healthcare Ltd. ©Springer Healthcare Ltd. All rights reserved. Neither of these parties endorse or recommend any commercial products, services, or equipment.

Kirsty Oswald

Written by

Kirsty Oswald

Kirsty has a B.Sc. in Human Sciences from University College London. After several years working as medical copywriter, she became a medical journalist and is now freelance. Kirsty also works part-time as an editor for a London-based charity. She is particularly interested in the social and cultural aspects of science.


Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Oswald, Kirsty. (2018, August 23). Capillary pCO2 helps determine IPAH diagnosis. News-Medical. Retrieved on November 29, 2021 from

  • MLA

    Oswald, Kirsty. "Capillary pCO2 helps determine IPAH diagnosis". News-Medical. 29 November 2021. <>.

  • Chicago

    Oswald, Kirsty. "Capillary pCO2 helps determine IPAH diagnosis". News-Medical. (accessed November 29, 2021).

  • Harvard

    Oswald, Kirsty. 2018. Capillary pCO2 helps determine IPAH diagnosis. News-Medical, viewed 29 November 2021,


The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
You might also like... ×
Novel strategy to produce SARS-CoV-2 nucleocapsid protein for serological testing